(17beta)-17-Hydroxyandrost-4-en-3-one | API EU Written Confirmation | WC | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

(17beta)-17-Hydroxyandrost-4-en-3-one
EU WC

PharmaCompass Sponsored Ads

Contact Supplier

Hubei Gedian Humanwell Pharmaceutical Testosterone

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

(17beta)-17-Hydroxyandrost-4-en-3-one

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 22 USDMF, 8 CEP/COS, 6 EU WC, 43 NDC API, 17 Listed Suppliers, $ API Reference Price

36 API Suppliers
22 USDMF
8 CEP/COS
6 EU WC
43 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

126 FDF Dossiers, 60 FDA Orange Book, 39 Europe, 7 Canada, 7 Australia, 8 South Africa, 5 Listed Dossiers

126 FDF Dossiers
60 FDA Orange Book
39 Europe
7 Canada
7 Australia
8 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL, METERED;NASAL - 5.5MG/0.122GM ACTUATION, GEL, METERED;TRANSDERMAL - 12.5MG/1.25GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 25MG/2.5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 50MG/5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 50MG/5GM PACKET, TABLET, EXTENDED RELEASE;BUCCAL - 30MG, GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION), GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL, METERED;NASAL - 5.5MG/0.122GM ACTUATION
GEL, METERED;TRANSDERMAL - 12.5MG/1.25GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 25MG/2.5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 50MG/5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 50MG/5GM PACKET
TABLET, EXTENDED RELEASE;BUCCAL - 30MG
GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION)
GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 2 DKSH, 1 Jai Radhe Sales, 6 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 BioSpectra, 2 Clariant, 15 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Lubrizol Life Science Health, 14 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

75 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 35 Topical, 33 Direct Compression, 30 Controlled & Modified Release, 25 Thickeners and Stabilizers, 21 Disintegrants & Superdisintegrants, 21 Granulation, 19 Lubricants & Glidants, 19 Co-Processed Excipients, 16 Film Formers & Plasticizers, 16 Solubilizers, 13 Parenteral, 7 Taste Masking, 6 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents

75 Fillers, Diluents & Binders
44 Coating Systems & Additives
35 Topical
33 Direct Compression
30 Controlled & Modified Release
25 Thickeners and Stabilizers
21 Disintegrants & Superdisintegrants
21 Granulation
19 Lubricants & Glidants
19 Co-Processed Excipients
16 Film Formers & Plasticizers
16 Solubilizers
13 Parenteral
7 Taste Masking
6 Chewable & Orodispersible Aids
6 API Stability Enhancers
6 Emulsifying Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 120 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
120 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 36 Finished Drug Prices, 12 Annual Reports

7 US Medicaid Prescriptions
36 Finished Drug Prices
12 Annual Reports

MARKET PLACE

8 APIs, 2 FDF Dossiers

8 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 8 Health Canada Patents

41 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

10 EDQM, 1 USP, 6 Others

10 EDQM
1 USP
6 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ API Ref.Price (USD/KG) : 436 Xls

Filters

Reset all filters

Filters

FILTER :

filter Name of the Firm Reset all filters

6 All

01 1M/S Symbiotec Pharmalab

02 1M/s. Symbiotec Pharmalab Ltd

03 1M/s IPCA laboratories ltd

04 1M/s Ipca Laboratories

05 1M/s. Sun Pharmaceuticals Ltd.

06 1M/sIPCA Laboratories Limited

filter Product Name Reset all filters

6 All

01 1Testosterone (BP/ Ph.Eur /USP)

02 1Testosterone (USP/BP/Ph.Eur)

03 1Testosterone BP/EP/USP

04 1Testosterone Decanoate EP/BP

05 1Testosterone Isocaproate EP/BP

06 1Testosterone USP/EP/ Testosterone cypionate USP

filter WC Number Reset all filters

6 All

01 1WC-0161A2

02 1WC-0162

03 1WC-0168

04 1WC-0402

05 1WC-0402A2

06 1WC-0402A3

filter Country Reset all filters

6 All

01 6India

Aspen Testosterone

List of Suppliers

Product Main Page

01

Symbiotec Pharmalab

CPhI India 2024

Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

Contact Supplier

Contact Supplier

Digital Content

Testosterone (BP/ Ph.Eur /USP)

Date of Issue : 2022-08-31

Valid Till : 2025-07-02

Written Confirmation Number : WC-0162

Address of the Firm : Plot No. 5, 6, 7 & 8 Special Economic Zone, Phase II, Pithampur, Dist: Dhar, MP-...

Symbiotec Pharmalab

Product Web Link

Digital Content

Corporate PDF

02

Symbiotec Pharmalab

CPhI India 2024

Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

Contact Supplier

Contact Supplier

Digital Content

Testosterone BP/EP/USP

Date of Issue : 2022-07-05

Valid Till : 2025-07-02

Written Confirmation Number : WC-0161A2

Address of the Firm : 385/2, Pigdamber, Rau, Indore-453 331, MP, India

Symbiotec Pharmalab

Product Web Link

Digital Content

Corporate PDF

03

Ipca Laboratories

2024 ACI Convention

Not Confirmed

Ipca Laboratories

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Testosterone (USP/BP/Ph.Eur)

Date of Issue : 2020-07-06

Valid Till : 2023-05-24

Written Confirmation Number : WC-0402

Address of the Firm : Plot no. 23-24 GIDC Estate Nandesari-391340 Dist Vadodara Gujarat India

Product Web Link

Digital Content

04

Ipca Laboratories

2024 ACI Convention

Not Confirmed

Ipca Laboratories

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Testosterone Isocaproate EP/BP

Date of Issue : 2020-11-12

Valid Till : 2023-05-24

Written Confirmation Number : WC-0402A3

Address of the Firm : Plot no. 23-24 GIDC Estate Nandesari-391340 Dist Vadodara Gujarat

Product Web Link

Digital Content

05

Ipca Laboratories

2024 ACI Convention

Not Confirmed

Ipca Laboratories

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Testosterone Decanoate EP/BP

Date of Issue : 2020-09-08

Valid Till : 2023-04-24

Written Confirmation Number : WC-0402A2

Address of the Firm : Plot no. 23-24 GIDC Estate Nandesari-391340 Dist Vadodara Gujarat

Product Web Link

Digital Content

06

Sun Pharmaceutical Industries Limited

2024 ACI Convention

Not Confirmed

Sun Pharmaceutical Industries Limited

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Testosterone USP/EP/ Testosterone cypionate USP

Date of Issue : 2019-07-15

Valid Till : 2022-07-14

Written Confirmation Number : WC-0168

Address of the Firm : Plot No.24/2 & 25, Phase-IV, GIDC, Industrial Zone, Panoli-394 116, Dist-Bharuch

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

(17beta)-17-Hydroxyandrost-4-en-3-one Manufacturers | Traders | Suppliers

(17beta)-17-Hydroxyandrost-4-en-3-one Manufacturers, Traders, Suppliers 1

38

We have 3 companies offering (17beta)-17-Hydroxyandrost-4-en-3-one

Get in contact with the supplier of your choice:

Symbiotec Pharmalab
Ipca Laboratories
Sun Pharmaceutical Industries Limited

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?